CARL Analyst Ratings & Price Targets

CARLCARL

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

2 analysts·Low coverage

100%

Rating Distribution

Strong Buy

00%

Buy

2100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 66% higher.

Bear Case

$18.00

+44%

Consensus

$20.67

+66%

Bull Case

$24.00

+93%

Price Range2 analysts

Low

Consensus

High

$18.00

$24.00

Current Target

Current Price

$12.46

Upside to Target

$8.21

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-1.66(3 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+46.43%

EPS—

FY2028

Rev+41.87%

EPS—

Earnings Surprises

Beat rate:100%(2/2 quarters)

Avg surprise:+7.2%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026Goldman Sachs

Carlsmed price target raised to $20 from $19 at Goldman Sachs

Target:$20.00

+55.4%from $12.87

Dec 15, 2025BTIG

BTIG Reiterates Buy Rating on Carlsmed Inc (CARL)

Target:$24.00

+85.3%from $12.95

Aug 18, 2025Piper Sandler

Carlsmed initiated with an Overweight at Piper Sandler

Target:$18.00

+32.5%from $13.58

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance